POTENSI DAUN STEVIA (STEVIA REBAUDIANA) SEBAGAI ANTIDIABETES: STUDI LITERATURE REVIEW

Abstract

Diabetes mellitus is one of the leading causes of death worldwide. The high prevalence of diabetes mellitus is caused by uncontrolled blood sugar levels in the body. Unhealthy dietary habits, such as the consumption of artificial sweeteners by diabetics, can also trigger an increase in blood glucose levels. Stevia (Stevia rebaudiana) is a natural sweetener that contains various active compounds with potential as alternative therapeutic agents, such as stevioside and rebaudioside, as well as other active ingredients that can lower blood glucose levels in the body. The aim of this study is to provide insight into the potential use of stevia as an alternative treatment for diabetes mellitus. The research method used was a literature review from two sources, PubMed and Google Scholar, employing the PICO and MeSH methods. The inclusion criteria for selecting the literature were articles and journals examining the potential of Stevia rebaudiana leaves as an antidiabetic agent, both national and international, relevant to the topic, using keywords such as 'Diabetic', 'Antidiabetic', 'Stevia rebaudiana', 'Sweet Leaf', and 'Blood Sugar', with a publication range from 2017–2024. The exclusion criteria excluded journals with irrelevant titles, paid journals, duplicate journals, incomplete texts, and off-topic content. The review results initially identified 17,000 journals from Google Scholar and 33 journals from PubMed. After screening, 30 eligible journals were selected. The conclusion indicates that Stevia rebaudiana has potential as a treatment for diabetes mellitus.